ヒト免疫不全症ウイルス1p24抗原・HIV抗体キット 全般的な
Contents
1. 4 2 1 5 2 5 3 HIV Ag Ab 15 2 5 6 4 5 1 0 1 5 2 5 2 1 HIV Ag Ab 5 1 2 HIV Ag Ab 12. BQX02T 2012 8 2 2012 1 1 22400AMX00095000 1 p 2 4 H I V HIV Hg Hp 1 2 HIV 3 HIV 1 HIV 2 HIV 1p24 4 5 DP 6
3. 9 5 8 g mL 2 4 0 pg mL G1200 S 1 1 2 HIV Ag Ab 1 5 2 5 6 1 4 0
4. HIV 1 H 1IV 2 H I V 1p24 150L 2 0 HIV Ag Ab 100zL 1 5 0 L HIV Ag Ab 1 2 0 HIV 1 gp41 HIV 2 gp36 HIV 1p24 N 1 9 HIV 1p24 N 3 3 H I V 1 HI V 2 HIV 1p24 3 7 1 0
5. 5 6 HIV 1 HI V 2 HIV 1p 2 4 HIV Human Immunodeficiency Virus H I V 27 AMP PD CLE IA chemiluminescent enzyme immunoassay G1200 1 1 3 5 2 3 3 6 6 5
6. 4 HI V 1 HI I V 2 HI 1p24 HIV Ag Ab HI V 1 HIV 2 HIV 1ps24 C O I 1 3 3 0 1 1
7. HIV 1 HIV 2 HIV 1p2 4 HIV 1 HIV 2 HIV 1p24 HIV 1 g p 4 1 HIV 2 g p 3 6 HIV 1p24 1 5 0 3 7 1 0 200 L 3 7 C 5
8. 2 1 2 HIV Ag Ab 6 0 mL 5
9. 2 62 5
10. 4 5 6 7 8 9 EDTA EDTA 2 0mg mL 2 0U mL 7 6 mg mL
11. C O T 1 0 3 1 3 0 0 0 5 2 2 2 1 HIV 1 HIV 2 AIDS HIV 1 HIV 2 HIV 1p 24 2 Wa 3 HIV RE A
12. 13 ALP 14 3 3 4 a 9 3 1 1 0 0 05
13. G1200 1 0 0 3 4 1 0 1 5 2 5 2 1 2 3 1 2 HIV Ag Ab MES 4
14. a uae ye 2 3 4 ai mm me 2 H I V 1 1 6 1 p 2 4 H VV 2 A CL IA B EL ISA sa me 3 106 EDTA me mm gm et me mm 3 6 HIV 1 2 HIV HIV 1 i 0 RNAN COU PRB953 4 000 80 000 700 000 1 000 000 PRB954 PRB955 1 000 70 000 400 000 gt 800 000 700 000 PRB958 200 2 000 200 000 500 000 40 000 gt 800 0
15. 6 7 HIV Ag Ab 8 HIV Ag Ab 1 5 2 5 C 10 HIV Ag Ab 11 HIV Ag Ab 12
16. 47 7 nm AMP PD TV 1 HIV 2 HTIV 1p 24 H I 1 H I 2 HIV 1p24 1 1 2 2 0 10 25 3
17. A HIV 1 C O I 1 0 4 0 B TV 2 C O I 1 0 4 0 HIV 1p24 C O I 1 0 2 0 6 D 1 V 1 C O 1 4 0 15 0 1 V 2 C O 1 4 0 15 0 F HIV 1p24 C O I 4 0 15 0 G C O I 1 0 C O IL 1 0 I C O I 1 0 NTIBSC National Institute for Biological Standards and Control WHO International Standard HIV 1P24 Antigen NIBSC code 90 636 HIV 1p 24 7 0 0mTIU mL 2 1 15 4 5 8 9 6 1 p 2 4 H I V 2 A CLIA B ELISA
18. 1 30xL 120 100 3 1 2 3 4 1 2 HIV Ag Ab US i 4 5 HI V 1 HI V 2 HI
19. 2 1 7 10 11 HAMA Human Anti Mouse Antibodies HAMA 5 4 0 n g mL 2 1 F C 1 9 7mg dL 21 0mg dL 488mg dL 1550 2 H I V 6 5 5 ME DL 1506 Mg mL 1 6 EE ee 240 7 0 9 2 8 ga g mL
20. 6 1 6 0mL 2 1 5 3 AMPPD 3 2 spiroadamantane 4 methoxy 4 3 phosphoryloxy phenyl 1 2 dioxetane disodium salt 3 2 2 4 4 3 1 2 2 HIV 1p24 TV 1 HI V 2 HI V 1 HIV MI A ed gt G1200 S 2 2 HIV Ag Ab 5 1
21. A 2 1 4 4CWOeo HO 7 G1200 8 a Re 5S 7 14 X3 42 X2 pa I G2 4 150 gL 150 L 2 250 L 250 3 120 prL 1 3 eomxir 4 HIV Ag Ab HIV Ag Ab 2 0 mLX1 2 0 mLX2 P Hrv Ag Ab 2 0 mLX1 2 0 mLX2 OO 1 6 1000mLX1 1 gb41 HIV 2 gp 36 HIV
22. 1 1 2 A 0 7 8
23. 1p24 HIV Ag Ab HI V 1 TV 2 HIV 1p2 4 C O 1I 1 3 0 3 3 l C O 1 C O I O I S C HIV Ag Ab X0 2 5 6 O C O I 1 0
24. 10 9 2 10 9 2 10 9 295335 HIV Ag Ab 295328 1 4 X 3 42 X2 HIV Ag Ab 219973 292600 219942 100mL 6 S0mLX 6 00 1 1 Barre Sinouss1i F et al Isolation of a T lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome AIDS Science 220 868 871 1983 2 Clavel F et al Isolation of a New Human Retrovirus from West African Patients with AIDS Science 233 343 346 1986 3 Nishizono I et al Rapid and Sensitive Chemiluminescent Enzyme Immunoassay for Measuring Tumor Markers Clin Chem 37 1639 1644 1991 TEL 0120 292 832 FAX 03 5695 9234
25. 1p 2 4 N 1 9 HIV 1p24 N 3 3 2 ALP HITV 1 gp41 ALP HIV 2 g p 3 6 ALP HIV 1p24 3 1 0 1 4 HIV Ag Ab HIV Ag Ab HIV Ag Ab ITV 1 p 24 5 AMP PD 3
26. HIV Ag Ab 0 1 2 4 1000ppm 1 2 1 1 2 1 2 0 5 1000ppm 1 29 1 ea 3 2 1 0 9 2 1 0 9 2 10 9 HIV Ag Ab 2
27. rt 0 HIV 1p 24 4 HI 1p2 4 IV 1 I 2 HIV 1p24 HIV 1p24
28. 00 BLD Below Limits of Detection PRB961 5 lt 50 lt 50 lt 50 lt 50 lt 50 lt 50 480 150 000 i 200 000 PRB963 lt 50 lt 50 lt 50 lt 50 7 800 96 000 620 000 4 HIV Ag Ab HIV 1p 2 4 7 00mIU mL NIBSC National Institute for Biological Standards and Control WHO International Standard HIV 1P24 Antigen NIBSC code 90 636 1 1 HIV HBV HCV 2 pH10 4
Download Pdf Manuals
Related Search